Cannabis Industry Journal

Cannabis packaging decisions have downstream consequences for compliance, operations, customer perception, and margins. This article offers a practical framework for evaluating packaging suppliers across five dimensions: compliance, product quality, operational fit, customization, and partnership reliability. It closes with a pre-commitment checklist that operators can use before signing any supplier agreement.

As cannabis becomes a globally traded medical commodity, cGMP compliance is reshaping how it is grown, handled, and transported. For operators working with imported biomass, controlling contamination and ensuring consistency across supply chains has become a defining challenge. That challenge was a central focus at the International Cannabis Business Conference in Berlin, where a panel on Good Manufacturing Practices (GMP) examined how operators can meet the European Union’s stringent standards for medical cannabis.

Legalization has been framed as a turning point for cannabis safety, transparency, and adoption for years, but now, over a decade since recreational cannabis sales began, American consumers are taking a closer look and asking tougher questions about whether the industry is living up to that standard.

Most cannabis operators have a banking problem. For many, that means limited access to financial services, forcing the business to operate largely in cash and be unable to use the standard banking rails every other industry takes for granted. The banking conversation in this industry almost always stops at access. Can the business get an account? Can it keep one?

Cannabis cultivation is, at its core, a controlled environment business, and air quality remains one of the most consistently underestimated variables in the operation. Contaminated batches, worker health complaints, and odor violations affecting neighboring communities can all be traced back to air-handling decisions made early in facility design or overlooked during scale-up. Mandatory testing gets attention, but prevention rarely does. The following five mistakes are showing up more and more across licensed facilities today, and each one carries the potential for high costs, both in revenue and to the brand.

Choosing between glass and plastic packaging for cannabis concentrates is a strategic decision with downstream consequences for product integrity, compliance, consumer perception, margins, and brand positioning. This article compares the two materials across five dimensions and offers a decision framework for operators to match packaging to product type, brand strategy, and operational scale.

SOCi’s 2026 Local Visibility Index analyzed more than 350,000 business locations across 2,751 brands and found a gap every dispensary operator should take seriously. ChatGPT recommends 1.2% of those locations. Perplexity recommends 7.4%. Gemini reaches 11%.

Pre-rolls generated $4 billion in sales in 2025 and are projected to grow faster than any other top cannabis category, at a 10% compound annual growth rate, according to BDSA retail tracking data. Infused formats now account for 43% of the segment, and the category has grown by 271% since 2020.

Every conversation about cannabis risk follows the same script: Regulatory uncertainty, 280E, capital access, and maybe interstate commerce, depending on the room. None of that is wrong, and operators dealing with those pressures daily don’t need me to tell them they’re real.

For years, cannabis operators have accepted labeling inefficiencies as an unavoidable cost of doing business. Yet, many facilities still rely on fragmented, manual workflows that require employees to export spreadsheets, copy cannabinoid results, and rekey intricate terpene data into static label templates. This traditional approach actively drains productivity, inflates labor costs, and introduces unnecessary opportunities for human error. Fortunately, a new generation of labeling technology is changing that reality.